The president of the Argentine Society of Pediatrics (SAP), Omar Tabacco, endorsed this Tuesday the inoculation against the coronavirus for children between 3 and 11 years old with the Sinopharm vaccine, which he “recommended” after having had access to the scientific evidence available to the Ministry of Health.
“We want the boys to be vaccinated for their safety, to achieve herd immunity and to reinforce school attendance. Without a doubt, we recommend the vaccine “Tabacco said in statements made this morning to Radio Nacional.
The specialist acknowledged that the announcement made from the Ministry of Health last Friday, in relation to the vaccination of 6,000,000 girls and boys between 3 and 11 years old “took him by surprise,” that is why the entity met with the Ministry to see “what was the scientific evidence that they had, since they were not published.”
Despite the fact that many media and leaders who respond to Together for Change tried to use the position of the SAP to question the vaccination campaign and pose a scenario of confrontation with the Government, Tabacco explained the reasons for the statement: “There was a information that we did not have and both parents and our colleagues needed certainty. “
Likewise, the head of the pediatric entity emphasized that prior to the meeting with the authorities of the Ministry of Health and Education, all they had was “a publication of the British medical journal Lancet, with very good results in phase one and two, working on one three, but due to confidentiality these results are closed until the end of the study “although he clarified that “Anmat has access to this data, so it authorized it.”
In that sense, he stressed that the National Administration of Drugs, Food and Medical Technology (Anmat), “is a serious, prestigious and absolutely trustworthy entity.” In that way Tabacco put an end to the series of speculations that emerged in the last hours against the application of the Sinopharm vaccine.
On the other hand, the specialist said that the Ministry of Health showed the authorities of the SAP “the path that Anmat has traveled with the regulatory entities of China and the laboratory that produces the vaccine, in the surveillance of a study of phase three of the use of Sinopharm for this age group, and other statistical results of a potential regrowth of (the variant) Delta (of the coronavirus) “.
Faced with this scenario, the president of the SAP indicated that the vaccination plan for boys and girls “will be of two doses as in adults” and stated that “the initiative is to actively vaccinate in schools.”
“That is why the team from the Ministry of Education was part of the meeting,” he added in relation to the meeting that took place this Monday at the headquarters of the Health Ministry.
– .
